Cargando…
Ribavirin is not effective against Crimean–Congo hemorrhagic fever: observations from the Turkish experience()
Crimean–Congo hemorrhagic fever (CCHF) is a viral infection associated with a high mortality rate. Ribavirin is the only drug used in the treatment of this disease. Studies investigating the effectiveness of ribavirin in CCHF have been retrospective and to date have included only a small number of c...
Autores principales: | Ceylan, Bahadır, Calıca, Aylin, Ak, Oznur, Akkoyunlu, Yasemin, Turhan, Vedat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society for Infectious Diseases. Published by Elsevier Ltd.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110843/ https://www.ncbi.nlm.nih.gov/pubmed/23773242 http://dx.doi.org/10.1016/j.ijid.2013.02.030 |
Ejemplares similares
-
Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis
por: Soares-Weiser, Karla, et al.
Publicado: (2010) -
Crimean-Congo Hemorrhagic Fever Beyond Ribavirin: A Systematic Review
por: Fabara, Stephanie P, et al.
Publicado: (2021) -
Ribavirin for treating Crimean Congo haemorrhagic fever
por: Johnson, Samuel, et al.
Publicado: (2018) -
Comparative study between Ribavirin and Ribavirin plus Intravenous Immunoglobulin against Crimean Congo hemorrhagic fever
por: Salehi, Hassan, et al.
Publicado: (2013) -
675. Crimean-Congo Hemorrhagic Fever Beyond Ribavirin: A Systematic Review
por: Fabara, Stephanie P, et al.
Publicado: (2021)